Prevail Therapeutics Inc.
PRVL:NASDAQ
Prevail Therapeutics is developing disease-modifying gene therapies for patients with Parkinson's disease and other neurodegenerative disorders.
Streetwise Company Fact Sheet
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
